Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 18, 2010
Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed...
-
Jun 14, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wells Fargo Healthcare Conference on June 24th in Boston. Ray Elliott,...
-
Jun 11, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim...
-
Jun 10, 2010CE Mark approval includes specific indication for treatment of diabetic patients
Boston Scientific Corporation (NYSE: BSX) today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting...
-
Jun 2, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs 31st Annual Global Healthcare Conference on June 16th in...
-
May 26, 2010Randomized study of nearly 3,000 patients to evaluate Company's third-generation drug-eluting stent technology
Boston Scientific Corporation (NYSE: BSX) today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research...
-
May 25, 2010
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark and U.S. Food and Drug Administration (FDA) approval of its NC Quantum Apex™...
-
May 24, 2010Company's iLab® Ultrasound Imaging System compatible with leading X-ray systems
Boston Scientific Corporation (NYSE: BSX) today announced collaborations with Philips Healthcare and Siemens Medical Solutions to enable the use of...
-
May 20, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the annual EuroPCR Scientific Program, May...
-
May 19, 2010Company expands Sterling line of peripheral angioplasty balloon catheters to include long balloons designed for below-the-knee procedures
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a...
-
May 18, 2010Next-generation system strengthens Company's endometrial ablation portfolio for the treatment of menorrhagia
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its Genesys HTA™ System for the...
-
May 13, 2010
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration clearance of the ACUITY Break-Away™ Lead Delivery...
-
May 12, 2010Approval includes specific indication for treatment of diabetic patients
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark approval for its TAXUS® Element™ Paclitaxel-Eluting Coronary...
-
May 11, 2010
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to...
-
May 10, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and sponsored research at the 31st Annual...
-
May 4, 2010Results of study using Boston Scientific's WallFlex® Duodenal Stent presented at Digestive Disease Week®
Boston Scientific Corporation (NYSE: BSX) today announced results from a study demonstrating that endoscopic duodenal stenting is...
-
May 3, 2010EVIDENCE Trial to study Boston Scientific's Precision Plus™ Spinal Cord Stimulator System
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the EVIDENCE Clinical Trial, which compares the...
-
Apr 30, 2010Positive results to be presented for SpyGlass® Direct Visualization System, Radial Jaw® 4 Biopsy Forceps and WallFlex® Duodenal Stents
Boston Scientific Corporation (NYSE: BSX) today announced that multiple clinical abstracts examining the diagnostic and therapeutic utility of its...
-
Apr 29, 2010Educational forum includes lab training sessions and online community for urogynecologists, urologists and surgical gynecologists
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Pelvic Floor Institute™ -- a unique training forum and online...
-
Apr 27, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. District Court in Minnesota declined to accept the plea agreement between...
-
Apr 26, 2010Company records $1.8 billion goodwill impairment charge
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2010, as well as guidance for...
-
Apr 22, 2010Major advance in guidewire technology provides exceptional torque and flexibility for coronary procedures
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention...
-
Apr 21, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming Bank of America Merrill Lynch Health Care Conference in New...
-
Apr 19, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming Deutsche Bank Health Care Conference in Boston on May 4. Ray...
-
Apr 19, 2010Exclusive agreement promotes access to testing solutions for female urinary incontinence
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a four-year exclusive marketing agreement with Bladder Health...